Themis Medicare Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2018 Mar-2017 Mar-2016 Mar-2015
Growth matrix (%)        
Revenue growth (3.30) (6.80) 15.10 3.49
Op profit growth (24) (14) 112 (25)
EBIT growth (21) (0.20) 54.50 (2.70)
Net profit growth (29) (2) 162 130
Profitability ratios (%)        
OPM 11.90 15.10 16.40 8.90
EBIT margin 11.10 13.60 12.70 9.45
Net profit margin 5.39 7.37 7 3.08
RoCE 8.83 12.70 14.30 9.16
RoNW 1.76 3.52 6.11 2.68
RoA 1.07 1.73 1.97 0.74
Per share ratios ()        
EPS 12.20 17.70 17.50 6.06
Dividend per share -- -- 1.78 1.80
Cash EPS 4.23 9.39 5.16 (6.20)
Book value per share 184 169 86.90 69.90
Valuation ratios        
P/E 45.50 34.80 20.40 22.70
P/CEPS 132 65.50 69.20 (22)
P/B 3.02 3.65 4.11 1.97
EV/EBIDTA 19.10 17.10 10.10 8.12
Payout (%)        
Dividend payout -- -- 11.20 29.30
Tax payout (0.90) (9.10) (11) 19.70
Liquidity ratios        
Debtor days 102 80.70 73.10 77
Inventory days 85.40 89.90 94.70 116
Creditor days (62) (66) (89) (116)
Leverage ratios        
Interest coverage (2) (2.50) (2.40) (1.30)
Net debt / equity 0.43 0.48 1.53 2.22
Net debt / op. profit 2.92 2.25 2.97 7.32
Cost breakup ()        
Material costs (34) (33) (38) (46)
Employee costs (21) (18) (16) (16)
Other costs (33) (34) (30) (29)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Revenue 210 217 232 202
yoy growth (%) (3.30) (6.80) 15.10 3.49
Raw materials (72) (71) (88) (93)
As % of sales 34.20 32.60 37.70 45.90
Employee costs (45) (40) (36) (33)
As % of sales 21.30 18.50 15.60 16.10
Other costs (68) (73) (70) (59)
As % of sales 32.50 33.80 30.30 29.10
Operating profit 25 32.80 38.20 18
OPM 11.90 15.10 16.40 8.90
Depreciation (7.40) (7.50) (12) (11)
Interest expense (12) (12) (12) (15)
Other income 5.60 4.07 3.19 12.60
Profit before tax 11.30 17.60 17.10 4.54
Taxes (0.10) (1.60) (1.90) 0.89
Tax rate (0.90) (9.10) (11) 19.70
Minorities and other 0.06 -- 1.06 0.77
Adj. profit 11.30 16 16.30 6.21
Exceptional items -- -- -- --
Net profit 11.30 16 16.30 6.21
yoy growth (%) (29) (2) 162 130
NPM 5.39 7.37 7 3.08
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Profit before tax 11.30 17.60 17.10 4.54
Depreciation (7.40) (7.50) (12) (11)
Tax paid (0.10) (1.60) (1.90) 0.89
Working capital 14.40 4.34 0.61 (4.80)
Other operating items -- -- -- --
Operating cashflow 18.20 12.80 3.94 (11)
Capital expenditure (25) (57) 27 14.20
Free cash flow (6.50) (44) 31 3.34
Equity raised 233 179 95.30 94.10
Investments 23.90 22.40 2.05 1
Debt financing/disposal 95.90 78.60 118 155
Dividends paid -- -- 1.51 1.51
Other items -- -- -- --
Net in cash 346 236 248 255
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2019 Mar-2018 Mar-2017 Mar-2016
Equity capital 9.18 9.18 9.04 8.52
Preference capital -- -- -- --
Reserves 149 160 143 65.50
Net worth 158 169 152 74
Minority interest
Debt 81.80 80 82.40 128
Deferred tax liabilities (net) 17.30 20.70 21.30 4.05
Total liabilities 257 270 256 206
Fixed assets 126 128 133 123
Intangible assets
Investments 26.60 24.40 22.90 5.64
Deferred tax asset (net) 23.90 25.50 26.10 0.99
Net working capital 77.30 84.40 65.80 61.80
Inventories 53.60 49.60 48.40 58.30
Inventory Days -- 86.40 81.60 91.50
Sundry debtors 72.90 68.60 48.30 47.60
Debtor days -- 120 81.30 74.70
Other current assets 25 22.60 23.40 25.60
Sundry creditors (35) (31) (32) (35)
Creditor days -- 53.20 53.30 54.80
Other current liabilities (39) (26) (23) (35)
Cash 3.45 6.91 8.62 14.30
Total assets 257 270 256 206
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Gross Sales 202 184 212 226 233
Excise Duty -- -- 2.20 9.49 --
Net Sales 202 184 210 217 233
Other Operating Income -- -- -- -- --
Other Income 12.40 4.94 5.60 4.07 3.18
Total Income 214 189 215 221 236
Total Expenditure ** 166 181 184 184 193
PBIDT 48 7.21 30.60 36.90 42.90
Interest 12.90 11.80 11.90 11.80 12.30
PBDT 35.20 (4.60) 18.80 25 30.70
Depreciation 8.27 7.99 7.42 7.47 11.10
Minority Interest Before NP -- -- -- -- --
Tax -- -- -- -- 2.13
Deferred Tax 2.09 (1.80) 0.10 1.60 (0.90)
Reported Profit After Tax 24.80 (11) 11.20 16 18.30
Minority Interest After NP -- -- (0.10) -- --
Net Profit after Minority Interest 24.80 (11) 11.30 16 19.30
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 24.80 (11) 11.30 16 19.30
EPS (Unit Curr.) 27 (12) 12.20 17.70 22.70
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) 17.50 -- -- -- --
Equity 9.19 9.18 9.18 9.04 8.52
Public Shareholding (Number) -- -- -- 2,984,138 2,459,705
Public Shareholding (%) -- -- -- 33 28.90
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- 6,055,295 6,055,295
Non Encumbered - % in Total Promoters Holding -- -- -- 100 100
Non Encumbered - % in Total Equity -- -- -- 67 71.10
PBIDTM(%) 23.80 3.92 14.60 17 18.40
PBDTM(%) 17.40 (2.50) 8.95 11.60 13.20
PATM(%) 12.30 (5.90) 5.36 7.37 7.84